At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Loteprednol Etabonate Ophthalmic Gel, 0.38% (BID and TID) Versus Vehicle Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating Loteprednol Etabonate Gel (BID), Loteprednol Etabonate Gel (TID), and 2 other interventions for Inflammation and 2 related conditions. Completed, enrolled 514 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the safety and efficacy of loteprednol etabonate ophthalmic gel
Study Details
Timeline
Interventions
One drop of LE gel instilled into the study eye two times per day (BID) for 14 days
One drop of LE gel instilled into the study eye three times per day (TID) for 14 days.
One drop of vehicle instilled into the study eye two times per day (BID) for 14 days
One drop of vehicle instilled into the study eye three times per day (TID) for 14 days